Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-21

Clinical Trial Update: Pharmacogenetics of Acenocoumarol

View source ↗

Summary

This completed clinical trial investigates pharmacogenetic factors influencing acenocoumarol response and dosing in thromboembolic diseases. Sponsored by Univer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acenocoumarol (Acenocoumarol)

Snippet

Sponsor: University Hospital, Geneva | Conditions: Thromboembolic Diseases | Status: COMPLETED